Literature DB >> 9227316

Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes.

A M van Furth1, E M Verhard-Seijmonsbergen, R van Furth, J A Langermans.   

Abstract

The present study concerns the effect of the xanthine derivates lisofylline (LSF) and pentoxifylline (PTX) on the production of pro-inflammatory cytokines tumour-necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) and the de-activating cytokine interleukin-10 (IL-10) by human leucocytes during stimulation with lipopolysaccharide (LPS), heat-killed Gram-negative bacteria (GNB) or Gram-positive bacteria (GPB). The production of TNF-alpha and IL-1 beta by leucocytes stimulated with LPS, Haemophilus influenzae type b (Hib) or Streptococcus pneumoniae was inhibited by both drugs. The production of IL-10 by leucocytes stimulated with LPS and Hib was inhibited by both xanthine derivates only at 48 hr. However, incubation of leucocytes with S. pneumoniae in the presence of LSF or PTX stimulated the production of IL-10 about four- and twofold at 24 hr and 48 hr, respectively. In all instances, the extent of inhibition or enhancement of cytokine production by LSF or PTX was equal. The divergent effects of xanthine derivates on the IL-10 production indicate the existence of distinct intracellular pathways depending on whether leucocytes are stimulated by GPB or GNB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227316      PMCID: PMC1363846          DOI: 10.1046/j.1365-2567.1997.00252.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.

Authors:  D B Dubravec; D R Spriggs; J A Mannick; M L Rodrick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

Authors:  S J van Deventer; H R Büller; J W ten Cate; L A Aarden; C E Hack; A Sturk
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

3.  Genetic influence on cytokine production and fatal meningococcal disease.

Authors:  R G Westendorp; J A Langermans; T W Huizinga; A H Elouali; C L Verweij; D I Boomsma; J P Vandenbroucke; J P Vandenbrouke
Journal:  Lancet       Date:  1997-01-18       Impact factor: 79.321

4.  Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis.

Authors:  X Sáez-Llorens; O Ramilo; M M Mustafa; J Mertsola; C de Alba; E Hansen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 5.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra
Journal:  Immunol Today       Date:  1992-06

6.  Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.

Authors:  L Schandené; P Vandenbussche; A Crusiaux; M L Alègre; D Abramowicz; E Dupont; J Content; M Goldman
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

7.  Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.

Authors:  J Semmler; U Gebert; T Eisenhut; J Moeller; M M Schönharting; A Alléra; S Endres
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

8.  Messengers and mediators: interactions among lipids, eicosanoids, and cytokines.

Authors:  S Endres
Journal:  Am J Clin Nutr       Date:  1993-05       Impact factor: 7.045

9.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.

Authors:  S Haskill; C Johnson; D Eierman; S Becker; K Warren
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

10.  Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

Authors:  J Han; P Thompson; B Beutler
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  13 in total

1.  Pentoxifylline influences the autocrine function of organ cultured donor corneas and enhances endothelial cell survival.

Authors:  A C Ventura; M Böhnke
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain.

Authors:  Mariana L Vale; Verônica M Benevides; Daniela Sachs; Gerly A C Brito; Francisco A C da Rocha; Stephen Poole; Sérgio H Ferreira; Fernando Q Cunha; Ronaldo A Ribeiro
Journal:  Br J Pharmacol       Date:  2004-11-01       Impact factor: 8.739

3.  Effect of pentoxifylline on tumor suppressor and proto-oncogene apoptosis in sperm.

Authors:  David T Maxwell; John D Jacobson; Alan King; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2002-06       Impact factor: 3.412

4.  The effects of pentoxifylline on skeletal muscle contractility and neuromuscular transmission during hypoxia.

Authors:  Fatma Simsek-Duran; Mert Ertunc; Rustu Onur
Journal:  Indian J Pharmacol       Date:  2009-10       Impact factor: 1.200

5.  Pharmacological studies on the anti-inflammatory and immunomodulatory role of pentoxifylline and its interaction with nitric oxide (NO) in experimental arthritis in rats.

Authors:  Rishi Pal; Manju J Chaudhary; Prafulla Chandra Tiwari; Rajendra Nath; Suresh Babu; Kamlesh Kumar Pant
Journal:  Inflammopharmacology       Date:  2016-09-26       Impact factor: 4.473

6.  Pentoxifylline and its applications in dermatology.

Authors:  Iffat Hassan; Konchok Dorjay; Parvaiz Anwar
Journal:  Indian Dermatol Online J       Date:  2014-10

7.  Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice.

Authors:  Elżbieta Wyska; Artur Świerczek; Krzysztof Pociecha; Katarzyna Przejczowska-Pomierny
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-08       Impact factor: 2.441

8.  Effect of various concentrations of caffeine, pentoxifylline, and kallikrein on hyperactivation of frozen bovine semen.

Authors:  Ibrahim A H Barakat; Mohamed A Danfour; Fatma A M Galewan; Mohamed A Dkhil
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

9.  Pharmacologic immunosuppression of mononuclear phagocyte phagocytosis by caffeine.

Authors:  Ryan P Steck; Spencer L Hill; Evita G Weagel; K Scott Weber; Richard A Robison; Kim L O'Neill
Journal:  Pharmacol Res Perspect       Date:  2015-10-25

Review 10.  Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?

Authors:  Farnoosh Seirafianpour; Samaneh Mozafarpoor; Nima Fattahi; Afsaneh Sadeghzadeh-Bazargan; Melika Hanifiha; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-06-26       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.